USV Pvt Ltd

USV Pvt Ltd

Fortune 500 2024
+ 2 More
+ 2 More
OVERVIEW
FINANCIALS

About

USV was founded by Vithal Balkrishna Gandhi. Currently, his granddaughter, Leena Tewari, serves as the company's chairperson and Prashant Tewari holds the position of MD. The establishment is a 62 year old leading healthcare company which began as a joint venture with USV & P Inc. USA, a subsidiary of Revlon. The range of products include Active Pharmaceutical Ingredients (APIs), Fixed Dosages Formulations (FDF), Peptides, Biosimilars and Injectables. These are manufactured in the company’s cGMP compliant plants located in India. The products are shipped globally to 65+ countries. USV’s intellectual property portfolio consists of patent filings for 15 inventions of which 12 have been granted. All manufacturing sites are ISO-14001 and OHSAS 18001 certified thus conforming to world Environment, Health and Safety standards.

Incorporation Year: 1961
Headquarters: Mumbai, India
Top Management: Founder : Vithal Balkrishna Gandhi , Chairperson: Leena Gandhi Tewari , MD : Prashant Tewari
Industry: Pharma

Featured In Fortune India Ranking

Fortune 500 India
#433(2024)
#377(2022)
#326(2021)
#433(2024)#377(2022)#326(2021)
Ranking Trend Fortune 500 India

Financial Data 2024

Revenue
4,825
(INR Cr)
Net Operating Income
4,553
(INR Cr)
Assets
5,484
(INR Cr)
Profit
1,377
(INR Cr)
Net Worth
5,298
(INR Cr)

Financial Data

RevenueNet Operating IncomeProfitAssetsNet Worth
PARAMETERS2024202320222021202020192018201720162015201420132012201120102009
Revenue
(INR Cr)
4825
12.1%
4305
5.8%
4069
7.2%
3796
14.9%
3303
5.9%
3120
10.0%
2837
2.2%
2775
7.7%
2577
18.2%
2180
8.6%
2008
14.5%
1755
15.5%
1519
24.0%
1225
15.1%
1064
18.8%
896
-
Net Operating Income
(INR Cr)
4553
9.55%
4156
6.74%
3893
6.69%
3649
0.00%
3141
5.26%
2984
9.47%
2726
4.04%
2620
9.97%
2383
14.77%
2076
9.75%
1891
11.99%
1689
16.69%
1447
26.47%
1144
12.75%
1015
21.24%
837
24.43%
Profit
(INR Cr)
1377
19.7%
1151
6.6%
1080
4.3%
1036
28.9%
803
8.0%
744
53.9%
484
-19.8%
603
2.0%
591
33.4%
443
-7.3%
478
29.1%
371
31.2%
282
10.9%
255
15.4%
221
27.9%
173
-
Assets
(INR Cr)
5484
17.4%
4673
11.5%
4189
10.4%
3796
30.5%
2909
1.4%
2870
9.0%
2634
22.2%
2156
11.9%
1927
20.8%
1595
7.7%
1481
18.0%
1255
8.5%
1157
14.5%
1010
10.7%
913
8.2%
844
-
Net Worth
(INR Cr)
5298
17.4%
4513
11.7%
4041
9.9%
3677
0.0%
2759
0.5%
2745
9.3%
2512
23.4%
2035
13.1%
1800
13.3%
1589
7.6%
1477
18.1%
1251
16.1%
1077
7.0%
1007
10.8%
909
8.3%
839
2.8%
Employee Cost
(INR Cr)
726
24.9%
581
11.8%
520
4.9%
495
18.1%
419
17.7%
356
13.0%
315
11.0%
284
14.6%
248
22.2%
203
5.6%
192
24.2%
155
4.8%
148
52.6%
97
28.9%
75
29.8%
58
-
Interest Cost
(INR Cr)
3322100000023000
Cash & Bank Balance
(INR Cr)
123224221261969410082846796724010175288
Total Debt
(INR Cr)
0000000000113345

Key Financial Ratios

Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
PARAMETERS2024202320222021202020192018201720162015201420132012201120102009
Profit As % Of Revenues 28.6%26.7%26.5%27.3%24.3%23.9%17.0%21.7%23.0%20.3%23.8%21.1%18.6%20.8%20.8%19.3%
Profit As % Of Assets 25.1%24.6%25.8%27.3%27.6%25.9%18.4%28.0%30.7%27.8%32.3%29.5%24.4%25.2%24.2%20.5%
Profit As % Of Networth 26.0%25.5%26.7%28.2%29.1%27.1%19.3%29.6%32.9%27.9%32.4%29.6%26.2%25.3%24.3%20.6%
Interest Cost to EBITDA % 0.2%0.2%0.1%0.1%0.2%------0.6%0.8%0.1%0.1%0.3%
Debt to Equity Ratio --------0.000.000.000.000.000.000.000.01
RONW 28.1%26.9%28.0%28.2%25.2%28.3%21.3%27.5%30.4%24.4%35.1%27.4%22.9%26.6%25.3%17.0%
ROCE 35.2%34.4%36.6%36.9%32.0%38.2%34.6%33.0%36.2%30.8%39.9%29.8%27.4%27.8%30.3%18.9%